2009
DOI: 10.4049/jimmunol.0713433
|View full text |Cite
|
Sign up to set email alerts
|

Small Interfering RNA against Transcription Factor STAT6 Inhibits Allergic Airway Inflammation and Hyperreactivity in Mice

Abstract: In the context of allergic immune responses, activation of STAT6 is pivotal for Th2-mediated IgE production and development of airway inflammation and hyperreactivity. We analyzed whether gene silencing of STAT6 expression by RNA interference was able to suppress allergen-induced immune and airway responses. Knockdown effectiveness of three different STAT6 siRNA molecules was analyzed in murine and human cell cultures. The most potent siRNA was used for further testing in a murine model of allergen-induced air… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
49
1

Year Published

2009
2009
2021
2021

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 66 publications
(52 citation statements)
references
References 50 publications
2
49
1
Order By: Relevance
“…Also, a number of studies have reported that RNAi can be used in DCs to diagnose and treat bronchial asthma (36)(37)(38)(39). Darcan-Nicolaisen et al (40) discovered that the two major signs of allergic asthma in the OVA-induced asthma mouse model, which are airway inflammation and hyperactivity, were significantly ameliorated by signal transducer and activator of transcription 6 (STAT6) silencing in airway epithelial cells using the administration of siRNA nose drops. Moriwaki et al (41) demonstrated that siRNA-mediated suppressor of cytokine signaling 3 (SOCS3) gene silencing could suppress the airway reactivity and eosinophilic infiltration that was induced by allergenic stimulation in asthmatic mice.…”
Section: Discussionmentioning
confidence: 99%
“…Also, a number of studies have reported that RNAi can be used in DCs to diagnose and treat bronchial asthma (36)(37)(38)(39). Darcan-Nicolaisen et al (40) discovered that the two major signs of allergic asthma in the OVA-induced asthma mouse model, which are airway inflammation and hyperactivity, were significantly ameliorated by signal transducer and activator of transcription 6 (STAT6) silencing in airway epithelial cells using the administration of siRNA nose drops. Moriwaki et al (41) demonstrated that siRNA-mediated suppressor of cytokine signaling 3 (SOCS3) gene silencing could suppress the airway reactivity and eosinophilic infiltration that was induced by allergenic stimulation in asthmatic mice.…”
Section: Discussionmentioning
confidence: 99%
“…29) In mouse models of allergic bronchial asthma, development of AHR was inhibited by STAT6 gene knockout 16,17) and by the treatment with a STAT6 inhibitory peptide 18) or a short interfering RNA against STAT6. 30) In addition to the phosphorylation of STAT6, a significant increase in the level of phosphorylated STAT1 was also found in BSMs of the antigen-challenged mice (Fig. 2).…”
Section: Discussionmentioning
confidence: 78%
“…Research of methylation or generally imprinting pattern of regulatory region of STAT6 and other genes is also very interesting due to their effect on gene expression. Furthermore, influencing gene expression represents a very exciting field for research with a promising perspective for targeted therapy, as was outlined by Darcan-Nicolaisen et al 74 in a study demonstrating inhibition of allergy inflammation and hyperreactivity by STAT6 siRNA in mice.…”
Section: Resultsmentioning
confidence: 99%